New, automated shake and fire platforms from Copley cut the burden of MDI and nasal drug product testing.

The latest generation of Vertus® automated shake and fire platforms from Copley Scientific make it easy and intuitive to integrate automation into a wide range of drug product testing workflows to boost productivity, drive down test variability, and simplify training.

Arcus deprioritizes Gilead-partnered drug in prostate cancer, the latest hiccup in $1.6B collaboration

Arcus Biosciences is reducing further investment on its adenosine receptor antagonist in prostate cancer after reviewing interim data, according to its second quarter report. In

August 8, 2023

Insilico’s Potential Best-in-Class AI Drug for Sought-After Cancer Target

What You Should Know: InSilico Medicine, a clinical-stage company utilizing generative artificial intelligence (AI) for drug discovery, reveals the development of an orally bioavailable preclinical candidate

February 16, 2024

Almirall, Absci partner on dermatological drug development

Share this article The companies will develop treatment candidates for two targets in dermatology. Credit: Chokniti-Studio / Shutterstock.com. Almirall has entered an artificial intelligence (AI)-driven drug

November 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.